[Predicting response to therapy in breast cancer].


Molecular staging of breast cancer with microarray technologies leads to different gene expression profiles distinguishing 4 special groups: luminal A and B subtype, HER2 subtype and basal subtype. These 4 groups show a different prognosis as well as different behaviours and responses to adjuvant therapy. The development of gene expression profiles to… (More)
DOI: 10.1159/000127392


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics